AH
Aviva Holdings Portfolio holdings
AUM
$20.5M
This Quarter Return
+49.54%
1 Year Return
+117.01%
3 Year Return
-36.54%
5 Year Return
-22.08%
10 Year Return
–
AUM
$456M
AUM Growth
+$456M
(+44%)
Cap. Flow
-$971K
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Esperion Therapeutics
ESPR
|
$923K |
| 2 |
MacroGenics
MGNX
|
$48K |
Sector Composition
| 1 | Healthcare | 54.34% |
| 2 | Technology | 19.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $230M | 50.43% | 3,135,966 | – | – |
|
|
MDCO
2
DELISTED
Medicines Co
MDCO
| $106M | 23.17% | 3,778,742 | – | – |
|
3
Inseego
INSG
$185M
| $88.7M | 19.47% | 18,799,229 | – | – |
|
|
4
Esperion Therapeutics
ESPR
$448M
| $17.7M | 3.89% | 441,649 -23,000 | -5% | -$923K |
|
5
Solid Biosciences
SLDB
$427M
| $106K | 0.02% | 11,488 | – | – |
|
|
6
MacroGenics
MGNX
$112M
| – | – | -3,815 | Closed | -$48K |
|